Ocean Biomedical, Inc.
OCEA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $38,825 | $44,825 | $505,054 | $337,268 |
| - Cash | $0 | $4 | $328 | $1,076 |
| + Debt | $16,300 | $12,118 | $2,150 | $0 |
| Enterprise Value | $55,125 | $56,939 | $506,875 | $336,192 |
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | – | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | – | -$958 | -$328 |
| % Margin | – | – | – | – |
| Net Income | -$3,301 | – | $565 | -$62,344 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.12 | – | -0.047 | -0.043 |
| % Growth | – | – | -11.3% | – |
| Operating Cash Flow | -$4,180 | -$9,429 | -$747 | -$1,053 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$4,180 | -$9,429 | -$747 | -$1,053 |